Menu
GeneBe

INPP5E

inositol polyphosphate-5-phosphatase E, the group of Phosphoinositide phosphatases

Basic information

Region (hg38): 9:136428618-136439845

Previous symbols: [ "JBTS1" ]

Links

ENSG00000148384NCBI:56623OMIM:613037HGNC:21474Uniprot:Q9NRR6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • MORM syndrome (Definitive), mode of inheritance: AR
  • Joubert syndrome 1 (Definitive), mode of inheritance: AR
  • MORM syndrome (Moderate), mode of inheritance: AR
  • Joubert syndrome 1 (Strong), mode of inheritance: AR
  • Joubert syndrome (Supportive), mode of inheritance: AR
  • COACH syndrome 1 (Supportive), mode of inheritance: AR
  • MORM syndrome (Supportive), mode of inheritance: AR
  • Joubert syndrome with ocular defect (Supportive), mode of inheritance: AR
  • MORM syndrome (Moderate), mode of inheritance: AR
  • Joubert syndrome 1 (Strong), mode of inheritance: AR
  • MORM syndrome (Moderate), mode of inheritance: AR
  • Joubert syndrome 1 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Joubert syndrome 1; Mental retardation, truncal obesity, retinal dystrophy, and micropenis (MORM syndrome)ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingEndocrine; Genitourinary; Neurologic; Ophthalmologic; Renal16493448; 19668216; 19668215
Individuals may have renal issues (though most reported individuals did not have evidence of compromised renal function)

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the INPP5E gene.

  • Familial aplasia of the vermis (594 variants)
  • not provided (116 variants)
  • Joubert syndrome 1 (96 variants)
  • not specified (70 variants)
  • INPP5E-related condition (39 variants)
  • Inborn genetic diseases (36 variants)
  • Rod-cone dystrophy (18 variants)
  • Retinal dystrophy (10 variants)
  • Joubert syndrome and related disorders (9 variants)
  • MORM syndrome (7 variants)
  • Joubert syndrome 1;MORM syndrome (2 variants)
  • MORM syndrome;Joubert syndrome 1 (2 variants)
  • INPP5E-related disorder (1 variants)
  • 16 conditions (1 variants)
  • Leber congenital amaurosis (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the INPP5E gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
142
clinvar
12
clinvar
158
missense
9
clinvar
19
clinvar
272
clinvar
5
clinvar
1
clinvar
306
nonsense
7
clinvar
2
clinvar
9
start loss
1
clinvar
1
clinvar
2
frameshift
12
clinvar
7
clinvar
2
clinvar
21
inframe indel
5
clinvar
1
clinvar
6
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
14
21
4
39
non coding
24
clinvar
70
clinvar
33
clinvar
127
Total 28 30 308 218 46

Highest pathogenic variant AF is 0.000158

Variants in INPP5E

This is a list of pathogenic ClinVar variants found in the INPP5E region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-136428749-A-G Joubert syndrome 1 Likely benign (Apr 27, 2017)365866
9-136428762-A-G Joubert syndrome 1 Uncertain significance (Jan 13, 2018)365867
9-136428859-T-C Joubert syndrome 1 Benign (Apr 27, 2017)365868
9-136428864-C-T Joubert syndrome 1 Uncertain significance (Jan 13, 2018)914393
9-136428912-C-G Joubert syndrome 1 Uncertain significance (Jan 13, 2018)365869
9-136428928-A-G Joubert syndrome 1 Uncertain significance (Jan 12, 2018)365870
9-136428948-G-A Joubert syndrome 1 Uncertain significance (Jan 13, 2018)365871
9-136428954-G-A Joubert syndrome 1 Uncertain significance (Jan 13, 2018)365872
9-136428972-T-C Joubert syndrome 1 Benign (Apr 27, 2017)365873
9-136429045-C-T Joubert syndrome 1 Uncertain significance (Jan 13, 2018)365874
9-136429093-G-A Joubert syndrome 1 Uncertain significance (Jan 12, 2018)914905
9-136429116-G-A Joubert syndrome 1 Uncertain significance (Jan 12, 2018)914906
9-136429191-G-C Joubert syndrome 1 Uncertain significance (Jan 12, 2018)914907
9-136429347-A-G Joubert syndrome 1 Benign (Jun 14, 2018)365875
9-136429440-T-C Joubert syndrome 1 Uncertain significance (Jan 13, 2018)365876
9-136429462-G-A Joubert syndrome 1 Uncertain significance (Jan 13, 2018)912947
9-136429577-C-T Joubert syndrome 1 Benign/Likely benign (Jun 26, 2018)365877
9-136429662-C-T Joubert syndrome 1 Uncertain significance (Jan 13, 2018)912948
9-136429670-A-C INPP5E-related disorder Likely benign (Jul 14, 2021)3042809
9-136429684-G-A Familial aplasia of the vermis Likely benign (Feb 24, 2023)1628072
9-136429687-GC-G Familial aplasia of the vermis Pathogenic (May 04, 2023)581255
9-136429691-A-G Familial aplasia of the vermis Uncertain significance (Aug 19, 2022)216708
9-136429700-G-C Inborn genetic diseases Uncertain significance (Aug 12, 2022)2307004
9-136429703-TTC-T not specified Uncertain significance (Apr 12, 2022)1683371
9-136429711-CTG-C Familial aplasia of the vermis Pathogenic (Feb 23, 2015)217658

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
INPP5Eprotein_codingprotein_codingENST00000371712 1011204
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.003100.9951254450171254620.0000678
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5073553830.9270.00002434050
Missense in Polyphen87109.30.795981089
Synonymous-0.9881961791.090.00001181389
Loss of Function2.68821.40.3740.00000101244

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006360.0000618
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.0001020.0000971
Middle Eastern0.0001090.000109
South Asian0.0001040.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Converts phosphatidylinositol 3,4,5-trisphosphate (PtdIns 3,4,5-P3) to PtdIns-P2, and phosphatidylinositol 4,5- bisphosphate to phosphatidylinositol 4-phosphate. Specific for lipid substrates, inactive towards water soluble inositol phosphates. {ECO:0000269|PubMed:10764818}.;
Disease
DISEASE: Mental retardation, truncal obesity, retinal dystrophy, and micropenis (MORMS) [MIM:610156]: An autosomal recessive disorder characterized by moderate mental retardation, truncal obesity, congenital non-progressive retinal dystrophy, and micropenis in males. The phenotype is similar to Bardet-Biedl syndrome and Cohen syndrome Distinguishing features are the age of onset, the non-progressive nature of the visual impairment, lack of dysmorphic facies, skin or gingival infection, microcephaly, mottled retina, polydactyly, and testicular anomalies. {ECO:0000269|PubMed:19668215}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Inositol phosphate metabolism - Homo sapiens (human);Phosphatidylinositol signaling system - Homo sapiens (human);Phosphatidylinositol Phosphate Metabolism;Joubert syndrome;Metabolism of lipids;3-phosphoinositide degradation;Metabolism;Phosphatidylinositol phosphate metabolism;Synthesis of PIPs at the Golgi membrane;PI Metabolism;Phospholipid metabolism;ARL13B-mediated ciliary trafficking of INPP5E;Cargo trafficking to the periciliary membrane;Cilium Assembly;Organelle biogenesis and maintenance (Consensus)

Recessive Scores

pRec
0.114

Haploinsufficiency Scores

pHI
0.174
hipred
Y
hipred_score
0.699
ghis
0.565

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.659

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Inpp5e
Phenotype
embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; cellular phenotype; growth/size/body region phenotype; craniofacial phenotype;

Zebrafish Information Network

Gene name
inpp5e
Affected structure
pronephric glomerulus
Phenotype tag
abnormal
Phenotype quality
cystic

Gene ontology

Biological process
phosphatidylinositol biosynthetic process;biological_process;inositol phosphate dephosphorylation;phosphatidylinositol dephosphorylation
Cellular component
ruffle;cytosol;plasma membrane;cilium;axoneme;Golgi cisterna membrane
Molecular function
phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;inositol-polyphosphate 5-phosphatase activity